- Report
- January 2025
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- April 2024
- 84 Pages
Global
From €2282EUR$2,400USD£1,917GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- August 2019
- 488 Pages
Global
From €3802EUR$3,999USD£3,194GBP
- Report
- June 2021
- 265 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- February 2022
- 112 Pages
Global
From €2614EUR$2,750USD£2,196GBP
€5229EUR$5,500USD£4,393GBP
- Report
- July 2022
- 84 Pages
Global
From €5229EUR$5,500USD£4,393GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €3090EUR$3,250USD£2,596GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Book
- February 2024
- 160 Pages
- Book
- August 2024
Global
- Book
- June 2010
- 471 Pages
- Book
- September 2021
Global

The DNA Damage Response (DDR) market is a subset of the genomics industry that focuses on the detection and repair of DNA damage. DDR is a complex process that involves the recognition of damaged DNA, the activation of repair pathways, and the restoration of the original DNA sequence. DDR is essential for maintaining genomic integrity and preventing the development of diseases such as cancer.
DDR technologies are used in a variety of applications, including cancer diagnostics, drug discovery, and gene therapy. Companies in the DDR market are developing products and services that enable researchers to identify and repair DNA damage. These products include DNA repair enzymes, DNA damage detection kits, and DNA repair assays.
Companies in the DDR market include Thermo Fisher Scientific, Illumina, Agilent Technologies, Merck KGaA, and Bio-Rad Laboratories. Show Less Read more